LWC can support submissions to regulators such as EMEA and FDA. Work includes contribution to dossiers, estimation of disease prevalence to support orphan status claims and presentation to regulators with the client company.

Experience in this area includes three recent submissions to EMEA in the area of oncology and detailed analyses of rare diseases. Other work has included a number of new drug applications and safety updates.